S

Details - Information last confirmed on June 9, 2021

We has successfully developed a product that relieves patients from pain and increase their mobility. In addition human trials prove that it also modifies the disease know as osteoarthritis that is expected to affect nearly half a billion people in the next 30 years. Our company has already began Phase 3 clinical trials and has been awarded several patents. We aim our medical treat to be labeled as the modifying agent to treat osteoarthritis making it the first of it's kinds with drastic improvement within 6 months through the use of 1 IV a year. Testing supports continued success at inhibiting and modifying the disease to slow and possibly reverse negative effects of osteoarthritis.

Leased location with Total Rent of $133. Lease ends 12/2021 with One 1 year option. Hours of operation of 8am-6pm Monday to Friday with 3 FT employees.

Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.